DEBRA PALAZZI to Antibodies, Monoclonal
This is a "connection" page, showing publications DEBRA PALAZZI has written about Antibodies, Monoclonal.
Connection Strength
0.074
-
The value of budget impact analyses in evaluating targeted therapies-The case of RSV prophylaxis for preterm infants. Value Health. 2011 Jan; 14(1):201-2.
Score: 0.039
-
Prevalence of respiratory syncytial virus (RSV) risk factors and cost implications of immunoprophylaxis to infants 32 to 35 weeks gestation for health plans in the United States. Value Health. 2010 Jan-Feb; 13(1):77-86.
Score: 0.035